Assessment of the effect of contraceptive pills on the treatment of sexual dysfunction in women with polycystic ovary syndrome.

Phase 3

Conditions: Condition 1: Polycystic Ovary Syndrome. Condition 2: Sexual Dysfunction.

Registration Number: IRCT20150905023897N3

Lead Sponsor: Tarbiat Modares University

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: Female

Target Recruitment: 70

Inclusion Criteria

) Iranian women age 18- 404 years , 2) PCOS based on Rotterdam criteria (19), 3) women having Vitamin D3 level less than 20 ng/ml (base on the test), 4) women having sex in the last month, and 5) women who used non-hormonal contraceptives three months before the start of the study

Exclusion Criteria

included having the history of side effects (such as headache, vomiting from OCP), chronic diseases, including diabetes mellitus, hypertension, Vascular-Thrombi-Embolism (VTE), and thyroid, having the history for sterility, having no history of depression based on Beck Depression Inventory (BDI) questionnaire, having intention to conceive in near future, no need for OCP treatment, the having no history of Cushing's syndrome, adrenal hyperplasia, and adrenal tumor.

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sexual Fanction Score obtained in the Female Sexual Function Index (FSFI) questionnaire. Timepoint: At the start of the study and 3 and 6 months from the start of the treatment. Method of measurement: Female Sexual Function Index (FSFI) questionnaire.;The level of vitamin D 3 in the blood. Timepoint: At the start of the study and 3 and 6 months from the start of the treatment. Method of measurement: Biochemical examination of blood.

Secondary Outcome Measures